Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Extension Study of Brimonidine Tartrate Posterior Segment Drug Delivery System Biodegradation
2010-019079-32Phase 2Completed
- Sponsor
- Allergan
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-blind, single-arm trial of brimonidine in retinitis pigmentosa (RP) and age-related macular degeneration (AMD), sponsored by Allergan. Primary endpoint: Ocular safety and biodegradation of Brimo PS DDS implant. Started Apr 2010; status: completed.
02
Drugs
brimonidine
03
Conditions
retinitis pigmentosa (RP)age-related macular degeneration (AMD)
Beyond the preview
Go deeper on 2010-019079-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019079-32.